Cure Glaucoma Foundation

“No review was or will be conducted.”

“No documents available to the public.”

“Prior period adjustments for accruals = $3257”

“Program Service Accomplishments in 2020 the organization operated the following programs.Research - Several unique research initiatives and partnerships are underway or in development:NT-501 Cell Therapy for the Treatment of Glaucoma - the goal of this study is to use a nerve growth factor, called ciliary neurotrophic factor (CNTF), to regenerate nerve tissue damaged from glaucoma. The phase 1 trial at Stanford University was completed with no serious adverse events and the initial results suggested improvement of visual field, contrast sensitivity and increased nerve thickness.In 2019 and 2020 a grant from Cure Glaucoma Foundation funded Glaucoma Associates of Texas participation in a follow up study that included 10 patients. Our hope is that this study may unlock the key to regenerating nerve tissue in our glaucoma patients, and further our mission to help cure glaucoma.American Glaucoma Society MAPS Grant - 2020 marks the sixth year CGF has funded the AGS MAPS Program. This program supports early career glaucoma specialists and scientists by providing tools and resources to further their careers as potential leaders in the science, research and the specialty of glaucoma care.Catalyst for the Cure (CFC) Vision Restoration Initiative - 2020 marks the second year CGF has funded a grant to this important program, the goals of CFC are: 1. To develop a strategy for optic nerve cell transplantation 2. To develop neuroprotective therapies for glaucoma.In the past year, there has been significant progress on both fronts.Akron Children's Hospital Clinical Research: Development of an enzyme replacement therapy for primary congenital glaucoma (PCG) - The long-term goal of this project is to develop an Enzyme Replacement Therapy for the treatment of PCG using recombinant CYP1B1. A readily available efficacious and safe alternative method is critically needed to improve patient outcomes and their quality of life.Global Outreach - CGF sponsors Medical Mission Trips to provide care for patients in underserved countries:Cure Glaucoma Foundation's "Train the Trainer", glaucoma drainage device (GDD) implant, Mission Outreach Program - Many glaucoma patients in countries in Africa are greatly underserved. This program is designed to teach qualified ophthalmologists in those countries how to implant the drain and, within 18 months, they will in turn train another physician in their resident country how to do the same. By this process CGF, in partnership with New World Medical, will greatly expand access to effective glaucoma therapy for many people.We are currently in the process of training the second class of physicians and we expect to have nineteen graduates complete this program in 2021. After the initial pilot program a new class of 18 trainees from 2 countries has been identified and is currently in training. Our partners who have made this program possible are: New World Medical, the Eye Foundation Hospital, Lagos, Nigeria, the American Academy of Ophthalmology and Cure Glaucoma Foundation and its supportive donors.Access to Care - The purpose of the Access to Care Project (ACP) is to take a proactive approach to reduce the burden of blindness. ACP is designed to address the unmet needs of persons affected by glaucoma with limited financial resources. Patient care provided will include eye exams, surgical, and postoperative clinical care necessary to prevent disease progression and blindness.”